Lancaster General Health is a clinical research site located in Lancaster, Pennsylvania, United States 17603.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Lancaster General Health has participated in 16 clinical trials with 7 currently active.
Therapeutic areas: Cardiovascular Disease and Lipoprotein(a), Triple Negative Breast Cancer, Acute Coronary Syndrome.
Sponsors: Novartis Pharmaceuticals, Gilead Sciences, Lancaster General Hospital.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Lancaster
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lancaster General Health has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lancaster General Health has 16 clinical trials on record, with 7 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a), Triple Negative Breast Cancer, Acute Coronary Syndrome.
Lancaster General Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.